Offered by: Nemours Children's Health
Location: Jacksonville and Pensacola in Florida
A Phase 3 Study Assesing Subject Perception of Treatment Burden Using Weekly Versus Daily Injection
The purpose of this research study is to compare the treatment experience of a weekly Somatrogon injection schedule and a daily Genotropin® (somatropin) injection schedule.
Children with who have either isolated Growth Hormone Deficiency (GHD) or Growth Hormone insufficiency and are ages 3 to under 18.
Your child will be in this research study for about 24 weeks. Your child will need to visit the research site at least 6 times during the study and you will be called at least 3 times during the study.
There are 3 blood draws during this study.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.